$TCMD
TACTILE SYSTEMS TECHNOLOGY INC

2021 Q4 Form 10-K Financial Statement

#000155837022001758 Filed on February 23, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $61.73M $208.1M $59.24M
YoY Change 4.19% 11.18% 3.82%
Cost Of Revenue $29.61M $59.84M $30.11M
YoY Change -1.67% 10.17% 14.66%
Gross Profit $32.12M $148.2M $41.85M
YoY Change -23.25% 11.6% 1.83%
Gross Profit Margin 52.04% 71.24% 70.65%
Selling, General & Admin $26.14M $143.6M $20.76M
YoY Change 25.91% 9.62% -11.92%
% of Gross Profit 81.37% 96.87% 49.6%
Research & Development $1.774M $5.659M $1.370M
YoY Change 29.49% 7.5% 15.13%
% of Gross Profit 5.52% 3.82% 3.27%
Depreciation & Amortization $1.531M $3.681M $690.0K
YoY Change 121.88% 31.75% -28.13%
% of Gross Profit 4.77% 2.48% 1.65%
Operating Expenses $28.36M $150.0M $22.14M
YoY Change 28.08% 9.92% -10.55%
Operating Profit $3.765M -$1.762M $6.991M
YoY Change -46.15% -51.43% 15.57%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$377.0K -$531.0K $1.190M
YoY Change -131.68% -138.84% 693.33%
Pretax Income $3.388M -$2.293M $8.180M
YoY Change -58.58% 1.42% 31.94%
Income Tax $10.88M $9.518M -$3.940M
% Of Pretax Income 321.22% -48.17%
Net Earnings -$7.495M -$11.81M $12.11M
YoY Change -161.89% 1805.0% 182.94%
Net Earnings / Revenue -12.14% -5.68% 20.44%
Basic Earnings Per Share -$0.60 $0.62
Diluted Earnings Per Share -$377.6K -$0.60 $0.61
COMMON SHARES
Basic Shares Outstanding 19.82M 19.72M 19.42M
Diluted Shares Outstanding 19.72M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.23M $40.71M $47.86M
YoY Change -41.01% -30.53% 5.79%
Cash & Equivalents $28.23M $28.23M $47.86M
Short-Term Investments $0.00 $12.48M $0.00
Other Short-Term Assets $4.141M $4.141M $2.600M
YoY Change 59.27% 59.27% 4.0%
Inventory $19.22M $19.22M $18.56M
Prepaid Expenses
Receivables $49.48M $49.48M $43.85M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $113.5M $113.5M $123.6M
YoY Change -8.14% -8.13% 14.1%
LONG-TERM ASSETS
Property, Plant & Equipment $6.750M $30.73M $6.957M
YoY Change -2.98% 13.41% -6.09%
Goodwill $31.06M
YoY Change
Intangibles $54.08M $1.680M
YoY Change 3119.11% -68.37%
Long-Term Investments
YoY Change
Other Assets $1.998M $1.998M $2.074M
YoY Change -3.66% -83.76% 25.09%
Total Long-Term Assets $130.7M $130.7M $50.47M
YoY Change 158.99% 158.86% 16.25%
TOTAL ASSETS
Total Short-Term Assets $113.5M $113.5M $123.6M
Total Long-Term Assets $130.7M $130.7M $50.47M
Total Assets $244.3M $244.3M $174.1M
YoY Change 40.31% 40.3% 14.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.023M $5.023M $4.197M
YoY Change 19.68% 19.6% 9.21%
Accrued Expenses $5.262M $19.91M $4.423M
YoY Change 18.97% 10.59% -1.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.960M $2.960M
YoY Change
Total Short-Term Liabilities $34.46M $34.46M $26.71M
YoY Change 29.0% 29.07% 24.67%
LONG-TERM LIABILITIES
Long-Term Debt $51.79M $51.79M $0.00
YoY Change
Other Long-Term Liabilities $29.76M $29.76M $22.60M
YoY Change 31.68% 31.68% 27.68%
Total Long-Term Liabilities $81.58M $81.55M $22.62M
YoY Change 260.62% 260.84% 27.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.46M $34.46M $26.71M
Total Long-Term Liabilities $81.58M $81.55M $22.62M
Total Liabilities $116.0M $116.0M $49.34M
YoY Change 135.2% 135.38% 26.0%
SHAREHOLDERS EQUITY
Retained Earnings $8.245M $20.06M
YoY Change -58.89% -3.0%
Common Stock $20.00K $19.00K
YoY Change 5.26% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $128.2M $128.2M $124.8M
YoY Change
Total Liabilities & Shareholders Equity $244.3M $244.3M $174.1M
YoY Change 40.31% 40.3% 14.72%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$7.495M -$11.81M $12.11M
YoY Change -161.89% 1805.0% 182.94%
Depreciation, Depletion And Amortization $1.531M $3.681M $690.0K
YoY Change 121.88% 31.75% -28.13%
Cash From Operating Activities $5.606M $2.631M $5.040M
YoY Change 11.23% -5.83% 5500.0%
INVESTING ACTIVITIES
Capital Expenditures -$947.0K $2.103M -$500.0K
YoY Change 89.4% 2.14% -67.95%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$79.83M $0.00
YoY Change -455.27% -100.0%
Cash From Investing Activities -$947.0K -$82.18M -$500.0K
YoY Change 89.4% -507.27% -152.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.312M
YoY Change -20.22%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.169M 59.93M 1.110M
YoY Change 5.32% 2737.45% -42.19%
NET CHANGE
Cash From Operating Activities 5.606M 2.631M 5.040M
Cash From Investing Activities -947.0K -82.18M -500.0K
Cash From Financing Activities 1.169M 59.93M 1.110M
Net Change In Cash 5.828M -19.63M 5.650M
YoY Change 3.15% -178.24% 90.88%
FREE CASH FLOW
Cash From Operating Activities $5.606M $2.631M $5.040M
Capital Expenditures -$947.0K $2.103M -$500.0K
Free Cash Flow $6.553M $528.0K $5.540M
YoY Change 18.29% -28.16% 235.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2834000
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
5249000
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2300000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001027838
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19877786
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19492718
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrent
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-37799
CY2021 dei Entity Registrant Name
EntityRegistrantName
Tactile Systems Technology, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
3701 Wayzata Blvd, Suite 300
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55416
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1801204
CY2021 dei City Area Code
CityAreaCode
612
CY2021 dei Local Phone Number
LocalPhoneNumber
355-5100
CY2021 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.001 Per Share
CY2021 dei Trading Symbol
TradingSymbol
TCMD
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
826000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
337000
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5659000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5264000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5174000
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021Q2 dei Entity Public Float
EntityPublicFloat
1005798716
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19884724
CY2021 dei Auditor Firm
AuditorFirmId
248
CY2021 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2021 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28229000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47855000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49478000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43849000
CY2021Q4 us-gaap Net Investment In Lease
NetInvestmentInLease
12482000
CY2020Q4 us-gaap Net Investment In Lease
NetInvestmentInLease
10708000
CY2021Q4 us-gaap Inventory Net
InventoryNet
19217000
CY2020Q4 us-gaap Inventory Net
InventoryNet
18563000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4141000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2638000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
113547000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
123613000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6750000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6957000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23984000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20132000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
54081000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1680000
CY2021Q4 us-gaap Goodwill
Goodwill
31063000
CY2021Q4 tcmd Medicare Accounts Receivable Non Current
MedicareAccountsReceivableNonCurrent
12847000
CY2020Q4 tcmd Medicare Accounts Receivable Non Current
MedicareAccountsReceivableNonCurrent
9433000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10198000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1998000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2074000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
130723000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
50474000
CY2021Q4 us-gaap Assets
Assets
244270000
CY2020Q4 us-gaap Assets
Assets
174087000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5023000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4197000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2960000
CY2021Q4 tcmd Earn Out Current
EarnOutCurrent
3250000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12139000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11588000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5262000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4423000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
16000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2658000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2506000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2006000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3305000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1842000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34461000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26714000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
24857000
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
26933000
CY2021Q4 tcmd Earn Out Non Current
EarnOutNonCurrent
2950000
CY2021Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3108000
CY2020Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3235000
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
348000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23354000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19388000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
81582000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
22623000
CY2021Q4 us-gaap Liabilities
Liabilities
116043000
CY2020Q4 us-gaap Liabilities
Liabilities
49337000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19877786
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19492718
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119962000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104675000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8245000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20056000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
128227000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
124750000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
244270000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174087000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
208057000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187130000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189492000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
59844000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
54320000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
55256000
CY2021 us-gaap Gross Profit
GrossProfit
148213000
CY2020 us-gaap Gross Profit
GrossProfit
132810000
CY2019 us-gaap Gross Profit
GrossProfit
134236000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
86775000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
79634000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
78920000
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2428000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1489000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56802000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51343000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39450000
CY2021 tcmd Amortization Of Intangible Assets And Earn Outs
AmortizationOfIntangibleAssetsAndEarnOuts
739000
CY2020 tcmd Amortization Of Intangible Assets And Earn Outs
AmortizationOfIntangibleAssetsAndEarnOuts
197000
CY2019 tcmd Amortization Of Intangible Assets And Earn Outs
AmortizationOfIntangibleAssetsAndEarnOuts
194000
CY2021 us-gaap Operating Expenses
OperatingExpenses
149975000
CY2020 us-gaap Operating Expenses
OperatingExpenses
136438000
CY2019 us-gaap Operating Expenses
OperatingExpenses
123738000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1762000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-3628000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
10498000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-531000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1367000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
631000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2293000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2261000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11129000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9518000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1641000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11811000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-620000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10971000
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.60
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.58
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.60
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2019 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.56
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19719485
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19346929
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18919007
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19719485
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19346929
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19641143
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-11811000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-620000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
10971000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
31000
CY2020 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
5000
CY2019 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-3000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
34000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11811000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-646000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11005000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
89270000
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
9824000
CY2019 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-3391000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3053000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11005000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
112595000
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
10689000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1068000
CY2020 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1854000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2898000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-646000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
124750000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
10173000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3976000
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1173000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2312000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11811000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
128227000
CY2021 us-gaap Profit Loss
ProfitLoss
-11811000
CY2020 us-gaap Profit Loss
ProfitLoss
-620000
CY2019 us-gaap Profit Loss
ProfitLoss
10971000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3681000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2794000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3538000
CY2020 tcmd Amortization Of Premiums And Discounts On Securities Available For Sale
AmortizationOfPremiumsAndDiscountsOnSecuritiesAvailableForSale
-91000
CY2019 tcmd Amortization Of Premiums And Discounts On Securities Available For Sale
AmortizationOfPremiumsAndDiscountsOnSecuritiesAvailableForSale
-307000
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-10230000
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1233000
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
146000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
10173000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
10689000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9824000
CY2020 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
11000
CY2019 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-7000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4025000
CY2019 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-1148000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-20000
CY2021 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
200000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5629000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10405000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9112000
CY2021 tcmd Increase Decrease In Net Investment In Lease
IncreaseDecreaseInNetInvestmentInLease
1774000
CY2020 tcmd Increase Decrease In Net Investment In Lease
IncreaseDecreaseInNetInvestmentInLease
2561000
CY2019 tcmd Increase Decrease In Net Investment In Lease
IncreaseDecreaseInNetInvestmentInLease
8147000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-972000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-318000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7870000
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2294000
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1972000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
528000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1166000
CY2021 tcmd Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-614000
CY2020 tcmd Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-559000
CY2019 tcmd Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-625000
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
3414000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1389000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
551000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1490000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2677000
CY2021 tcmd Increase Decrease In Other Accrued Liabilities And Income Taxes Payable
IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable
2175000
CY2020 tcmd Increase Decrease In Other Accrued Liabilities And Income Taxes Payable
IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable
1308000
CY2019 tcmd Increase Decrease In Other Accrued Liabilities And Income Taxes Payable
IncreaseDecreaseInOtherAccruedLiabilitiesAndIncomeTaxesPayable
1729000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2631000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2794000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2510000
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1493000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
22500000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
25000000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
22840000
CY2021 tcmd Payments To Acquire Productive Asset
PaymentsToAcquireProductiveAsset
79829000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2103000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2059000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5446000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
252000
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
232000
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
542000
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
30000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82184000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20179000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2335000
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
30000000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
25000000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
188000
CY2021 tcmd Payment Of Taxes For Net Share Settlement Of Restricted Stock Units
PaymentOfTaxesForNetShareSettlementOfRestrictedStockUnits
1173000
CY2020 tcmd Payment Of Taxes For Net Share Settlement Of Restricted Stock Units
PaymentOfTaxesForNetShareSettlementOfRestrictedStockUnits
1854000
CY2019 tcmd Payment Of Taxes For Net Share Settlement Of Restricted Stock Units
PaymentOfTaxesForNetShareSettlementOfRestrictedStockUnits
3391000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3976000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1068000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2834000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2312000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2898000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3053000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59927000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2112000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2496000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-19626000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
25085000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2671000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47855000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22770000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20099000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28229000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47855000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22770000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
130000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
1593000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
543000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
344000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
23000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
17000
CY2019 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
122000
CY2021 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Note 1.  Nature of Business and Operations</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Tactile Systems Technology, Inc. (“we,” “us,” and “our”) is the sole manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. We provide these products through our direct sales force for use in the home and sell or rent them through vascular, wound and lymphedema clinics throughout the United States. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On September 8, 2021, we acquired the assets of the AffloVest respiratory therapy business (“AffloVest Acquisition”) from International Biophysics Corporation (“IBC”), a privately-held company which developed and manufactures AffloVest. AffloVest is a portable, wearable vest that treats patients with chronic respiratory conditions. The device is sold through respiratory durable medical equipment providers throughout the United States. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We were originally incorporated in Minnesota under the name Tactile Systems Technology, Inc. on January 30, 1995. During 2006, we established a merger corporation and subsequently, on July 21, 2006, merged with and into this merger corporation, resulting in us being reincorporated as a Delaware corporation. The resulting corporation assumed the name Tactile Systems Technology, Inc. In September 2013, we began doing business as “Tactile Medical.”</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-bottom:12pt;text-align:justify;text-indent:36pt;margin:0pt;">Our business is affected by seasonality. In the first quarter of each year, when most patients have started a new insurance year and have not yet met their annual out-of-pocket payment obligations, we experience substantially reduced demand for our products. We typically experience higher revenue in the third and fourth quarters of the year when patients have met their annual insurance deductibles, thereby reducing their out-of-pocket costs for our products, and because patients desire to exhaust their flexible spending accounts at year end. This seasonality applies only to purchases and rentals of our products by patients covered by commercial insurance and is not relevant to Medicare, Medicaid or the Veterans Administration, as those payers either do not have plans that have declining deductibles over the course of the plan year and/or do not have plans that include patient deductibles for purchases or rentals of our products. Further, seasonality trends have been, and may continue to be, significantly different than historical trends as a result of the COVID-19 pandemic and related impacts.</p>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:14pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and to disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020 tcmd Proceeds From Grant From Relief Fund
ProceedsFromGrantFromReliefFund
1200000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
300000
CY2021Q4 tcmd Marketable Securities In Unrealized Loss Position
MarketableSecuritiesInUnrealizedLossPosition
0
CY2021Q4 tcmd Percentage Of Claims Approved
PercentageOfClaimsApproved
0.90
CY2021 tcmd Medicare Receivables Time Period
MedicareReceivablesTimePeriod
P1Y
CY2021 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2019 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 tcmd Asset Acquisition Earnout Liability
AssetAcquisitionEarnoutLiability
6400000
CY2021Q3 tcmd Goodwill Amortization Period For Tax Purposes
GoodwillAmortizationPeriodForTaxPurposes
P15Y
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53500000
CY2021Q3 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P12Y3M18D
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2021 tcmd Unrealized Holding Gain Loss On Marketable Securities Arising During Period Before Tax
UnrealizedHoldingGainLossOnMarketableSecuritiesArisingDuringPeriodBeforeTax
0
CY2021 tcmd Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
0
CY2020Q4 tcmd Marketable Securities In Unrealized Loss Position
MarketableSecuritiesInUnrealizedLossPosition
0
CY2021 tcmd Concentration Risk Number Of Insurance Companies
ConcentrationRiskNumberOfInsuranceCompanies
2
CY2020 tcmd Concentration Risk Number Of Insurance Companies
ConcentrationRiskNumberOfInsuranceCompanies
2
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8242000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7129000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
10975000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
11434000
CY2021Q4 us-gaap Inventory Net
InventoryNet
19217000
CY2020Q4 us-gaap Inventory Net
InventoryNet
18563000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15793000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14333000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9043000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7376000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6750000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6957000
CY2021 us-gaap Depreciation
Depreciation
2300000
CY2020 us-gaap Depreciation
Depreciation
2400000
CY2019 us-gaap Depreciation
Depreciation
3000000.0
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
45916000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1900000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44016000
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
55981000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1900000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
54081000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1663000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
549000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1114000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2229000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
549000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1680000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3818000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3787000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3766000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3676000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3612000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
25357000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44016000
CY2021 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P12Y
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1851000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1606000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1371000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
882000
CY2021Q4 tcmd Accrued Travel And Entertainment Current
AccruedTravelAndEntertainmentCurrent
661000
CY2020Q4 tcmd Accrued Travel And Entertainment Current
AccruedTravelAndEntertainmentCurrent
545000
CY2021Q4 tcmd In Transit Inventory Accrued Expense
InTransitInventoryAccruedExpense
416000
CY2020Q4 tcmd In Transit Inventory Accrued Expense
InTransitInventoryAccruedExpense
634000
CY2021Q4 tcmd Accrued Clinical Studies Expenses Current
AccruedClinicalStudiesExpensesCurrent
113000
CY2020Q4 tcmd Accrued Clinical Studies Expenses Current
AccruedClinicalStudiesExpensesCurrent
67000
CY2021Q4 tcmd Accrued Sales And Use Tax
AccruedSalesAndUseTax
106000
CY2020Q4 tcmd Accrued Sales And Use Tax
AccruedSalesAndUseTax
193000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
744000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
496000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5262000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4423000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4841000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3759000
CY2021 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2606000
CY2020 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2957000
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2488000
CY2020 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1875000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4959000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4841000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1851000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1606000
CY2021Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3108000
CY2020Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3235000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4959000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4841000
CY2021Q3 tcmd Line Of Credit Threshold Contingent Increase In Borrowing Capacity
LineOfCreditThresholdContingentIncreaseInBorrowingCapacity
25000000.0
CY2021Q3 tcmd Credit Agreement Total Aggregate Principal Amount
CreditAgreementTotalAggregatePrincipalAmount
80000000.0
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
25000000.0
CY2019 tcmd Lease Termination Fee
LeaseTerminationFee
1200000
CY2019 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-1100000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23984000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20132000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2506000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2006000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23354000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19388000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
25860000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
21394000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
3379000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
2646000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6920000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6789000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3549000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3420000
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3414000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3516000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3615000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
13249000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
30763000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4903000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
25860000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2506000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23354000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3600000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3000000.0
CY2019 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2100000
CY2020Q4 tcmd Number Of Vendors
NumberOfVendors
2
CY2021Q4 tcmd Number Of Vendors
NumberOfVendors
2
CY2021Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
15100000
CY2016Q3 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
5924453
CY2016Q3 tcmd Stock Issued During Period Prior To Completion Of Initial Offering Shares New Issues
StockIssuedDuringPeriodPriorToCompletionOfInitialOfferingSharesNewIssues
2354323
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4539
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10200000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10700000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9800000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10173000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10689000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9824000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
14104000
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
11591000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
208057000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187130000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189492000
CY2021 tcmd Percentage Of Revenue
PercentageOfRevenue
1
CY2020 tcmd Percentage Of Revenue
PercentageOfRevenue
1
CY2019 tcmd Percentage Of Revenue
PercentageOfRevenue
1
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
208057000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187130000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
189492000
CY2019 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
5000000.0
CY2021 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
9622000
CY2020 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
9011000
CY2021 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
30143000
CY2020 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
25633000
CY2019 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
21570000
CY2019 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
7510000
CY2021 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
20521000
CY2020 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
16622000
CY2019 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
14060000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1274000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-653000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
205000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
214000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
294000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
100000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1060000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-359000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
305000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
7874000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-833000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-303000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2356000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-395000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
153000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10230000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1228000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-150000
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
348000
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-54000
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
3000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1641000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000
CY2021Q4 tcmd Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
6490000
CY2020Q4 tcmd Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
5329000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
671000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
312000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
4658000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
3887000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3777000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3558000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1104000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9518000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1489000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1245000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1206000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
579000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
612000
CY2021Q4 tcmd Deferred Tax Assets Business Credits
DeferredTaxAssetsBusinessCredits
682000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
199000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
107000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19405000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16500000
CY2021Q4 tcmd Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
6019000
CY2020Q4 tcmd Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
5016000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
914000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1286000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
378000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
87000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7398000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6302000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12039000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10198000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.011
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.079
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.073
CY2021 tcmd Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
-0.142
CY2020 tcmd Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
-0.055
CY2019 tcmd Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationPercent
0.091
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
-0.106
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
0.026
CY2020 tcmd Effective Income Tax Rate Reconciliation Incentive Stock Options
EffectiveIncomeTaxRateReconciliationIncentiveStockOptions
-0.004
CY2019 tcmd Effective Income Tax Rate Reconciliation Incentive Stock Options
EffectiveIncomeTaxRateReconciliationIncentiveStockOptions
0.002
CY2021 tcmd Effective Income Tax Rate Reconciliation Employee Stock Purchase Plan
EffectiveIncomeTaxRateReconciliationEmployeeStockPurchasePlan
-0.075
CY2020 tcmd Effective Income Tax Rate Reconciliation Employee Stock Purchase Plan
EffectiveIncomeTaxRateReconciliationEmployeeStockPurchasePlan
-0.086
CY2019 tcmd Effective Income Tax Rate Reconciliation Employee Stock Purchase Plan
EffectiveIncomeTaxRateReconciliationEmployeeStockPurchasePlan
0.017
CY2021 tcmd Effective Income Tax Rate Reconciliation Federal Business Credit Percent
EffectiveIncomeTaxRateReconciliationFederalBusinessCreditPercent
0.109
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5.250
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.080
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.017
CY2021 tcmd Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.065
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19719485
CY2020 tcmd Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0.036
CY2019 tcmd Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.004
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.602
CY2020 tcmd Effective Income Tax Rate Reconciliation Internal Revenue Service Exam
EffectiveIncomeTaxRateReconciliationInternalRevenueServiceExam
0.025
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0.033
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.001
CY2020 tcmd Effective Income Tax Rate Reconciliation Federal Carryback Claim Percent
EffectiveIncomeTaxRateReconciliationFederalCarrybackClaimPercent
0.385
CY2021 tcmd Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
-0.022
CY2020 tcmd Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits
EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
0.023
CY2021 tcmd Effective Income Tax Rate Reconciliation Excess Tax Benefit On Non Qualified Stock Options And Rsu
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitOnNonQualifiedStockOptionsAndRsu
0.472
CY2020 tcmd Effective Income Tax Rate Reconciliation Excess Tax Benefit On Non Qualified Stock Options And Rsu
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitOnNonQualifiedStockOptionsAndRsu
0.280
CY2019 tcmd Effective Income Tax Rate Reconciliation Excess Tax Benefit On Non Qualified Stock Options And Rsu
EffectiveIncomeTaxRateReconciliationExcessTaxBenefitOnNonQualifiedStockOptionsAndRsu
-0.415
CY2021 tcmd Effective Income Tax Rate Reconciliation Interest And Penalty Percent
EffectiveIncomeTaxRateReconciliationInterestAndPenaltyPercent
-0.007
CY2020 tcmd Effective Income Tax Rate Reconciliation Interest And Penalty Percent
EffectiveIncomeTaxRateReconciliationInterestAndPenaltyPercent
0.019
CY2019 tcmd Effective Income Tax Rate Reconciliation Interest And Penalty Percent
EffectiveIncomeTaxRateReconciliationInterestAndPenaltyPercent
-0.002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-4.151
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.726
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.014
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
54000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
51000
CY2021 tcmd Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
522000
CY2020 tcmd Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-54000
CY2019 tcmd Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
3000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
522000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
54000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12000000.0
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11811000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-620000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10971000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19346929
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18919007
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
722136
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19719485
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19346929
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19641143
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1269966
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1407983
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
387372
CY2020Q4 tcmd Fair Value Transfers Within Three Level Hierarchy
FairValueTransfersWithinThreeLevelHierarchy
0
CY2021 tcmd Asset Acquisition Earnout Liability
AssetAcquisitionEarnoutLiability
6400000
CY2021 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
200000
CY2021Q4 tcmd Fair Value Measure Earn Out Liability
FairValueMeasureEarnOutLiability
6200000
CY2021Q4 tcmd Fair Value Measure Earn Out Liability
FairValueMeasureEarnOutLiability
6200000
CY2021Q4 tcmd Fair Value Measure Earn Out Liability Non Current
FairValueMeasureEarnOutLiabilityNonCurrent
3000000.0

Files In Submission

Name View Source Status
0001558370-22-001758-index-headers.html Edgar Link pending
0001558370-22-001758-index.html Edgar Link pending
0001558370-22-001758.txt Edgar Link pending
0001558370-22-001758-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcmd-20211231.xsd Edgar Link pending
tcmd-20211231x10k.htm Edgar Link pending
tcmd-20211231x10k005.jpg Edgar Link pending
tcmd-20211231x10k006.jpg Edgar Link pending
tcmd-20211231x10k007.jpg Edgar Link pending
tcmd-20211231x10k008.jpg Edgar Link pending
tcmd-20211231x10k_htm.xml Edgar Link completed
tcmd-20211231xex10d23.htm Edgar Link pending
tcmd-20211231xex10d29.htm Edgar Link pending
tcmd-20211231xex10d29001.jpg Edgar Link pending
tcmd-20211231xex10d29002.jpg Edgar Link pending
tcmd-20211231xex10d30.htm Edgar Link pending
tcmd-20211231xex10d30001.jpg Edgar Link pending
tcmd-20211231xex10d30002.jpg Edgar Link pending
tcmd-20211231xex10d30003.jpg Edgar Link pending
tcmd-20211231xex10d37.htm Edgar Link pending
tcmd-20211231xex23d1.htm Edgar Link pending
tcmd-20211231xex31d1.htm Edgar Link pending
tcmd-20211231xex31d2.htm Edgar Link pending
tcmd-20211231xex32d1.htm Edgar Link pending
tcmd-20211231xex32d2.htm Edgar Link pending
tcmd-20211231xex4d1.htm Edgar Link pending
tcmd-20211231_cal.xml Edgar Link unprocessable
tcmd-20211231_def.xml Edgar Link unprocessable
tcmd-20211231_lab.xml Edgar Link unprocessable
tcmd-20211231_pre.xml Edgar Link unprocessable